In our study, the GSTM1 null genotype was more common in healthy controls (71.67%) than in bladder cancer patients (58.33%) without statistical significance (OR=0.55; 95% CI=0.26-1.18), (p=0.128). Here, GSTM1 is linked to urinary bladder carcinoma.